EcoDrugPlus

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSLACG00000006443
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSLACG00000012156
Gene Symbol: DDR2
4 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSLACG00000017600
Gene Symbol: DRD1
4 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSLACG00000018381
Gene Symbol: DRD2
4 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSLACG00000002004
Gene Symbol: DRD3
2 Cross references
206 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSLACG00000014568
Gene Symbol: DRD4
4 Cross references
246 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSLACG00000001704
Gene Symbol: DRD5
4 Cross references
186 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSLACG00000007935
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSLACG00000017899
Gene Symbol: EGLN2
4 Cross references
197 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSLACG00000018190
Gene Symbol: EGLN3
4 Cross references
209 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 1a

Ensembl ID : ENSLACG00000008756
Gene Symbol: EGLN1A
3 Cross references
234 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSLACG00000002597
Gene Symbol: EPAS1
4 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).